Emma Reeve
2020
In 2020, Emma Reeve earned a total compensation of $2.1M as Chief Financial Officer at CONSTELLATION PHARMACEUTICALS, a 89% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,970 |
|---|---|
| Option Awards | $1,518,570 |
| Salary | $397,288 |
| Other | $14,725 |
| Total | $2,081,553 |
Reeve received $1.5M in option awards, accounting for 73% of the total pay in 2020.
Reeve also received $151K in non-equity incentive plan, $397.3K in salary and $14.7K in other compensation.
Rankings
In 2020, Emma Reeve's compensation ranked 5,336th out of 13,090 executives tracked by ExecPay. In other words, Reeve earned more than 59.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,336 out of 13,090 | 59th |
Division Manufacturing | 2,192 out of 5,621 | 61st |
Major group Chemicals And Allied Products | 877 out of 2,254 | 61st |
Industry group Drugs | 755 out of 1,954 | 61st |
Industry Pharmaceutical Preparations | 566 out of 1,459 | 61st |
Source: SEC filing on April 23, 2021.
Reeve's colleagues
We found four more compensation records of executives who worked with Emma Reeve at CONSTELLATION PHARMACEUTICALS in 2020.